Skip to the page

Data / Drug companies / Kingsway Pharmaceuticals DBA Nfi, LLC

Kingsway Pharmaceuticals DBA Nfi, LLC: 11 products in the FDA NDC directory, labeler code 69993

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Kingsway Pharmaceuticals DBA Nfi, LLC (labeler code 69993) lists 11 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 11 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 1, 2026.

The request: Watch Kingsway Pharmaceuticals DBA Nfi, LLC (FDA labeler code 69993): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69993
Products in commercial distribution
11
Packages
12
Finished drugs by generic name
6
Prescription products
0
Over the counter products
11
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
June 4, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs11100%

Products by type

TypeProductsShare
Over the counter drugs11100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Trolamine salicylate39
Lidocaine2216
Tripelennamine 0.5%21
4% lidocaine23
Lidocaine cream 4%11
Tripelennamine hcl 1%11

Dosage forms

Dosage formProductsShare
Cream763.6%
Patch218.2%
Gel19.1%
Spray19.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Blue-Emu THRIVE Cooling69993-650CreamOver the counter monograph drugsJanuary 1, 2026
Blue-Emu Thrive Pain Relief Cream69993-600CreamOver the counter monograph drugsNovember 1, 2025
Bikini Zone Medicated Gel69993-044GelOver the counter monograph drugsSeptember 1, 2025
Bikini Zone Medicated Creme69993-043CreamOver the counter monograph drugsSeptember 1, 2025
Pbz otc69993-151CreamOver the counter monograph drugsFebruary 1, 2025
Blue-Emu Ultra with Hemp Seed69993-200CreamOver the counter monograph drugsApril 5, 2021
Blue-Emu Maximum Pain Relief69993-300CreamOver the counter monograph drugsAugust 1, 2020
Blue-Emu Lidocaine Pain Relief Cream69993-350CreamOver the counter monograph drugsMarch 1, 2017
Lidocare Arm, Neck, Leg69993-450PatchOver the counter monograph drugsMay 1, 2016
Lidocare 0369993-400PatchOver the counter monograph drugsMay 1, 2016
Maximum Strength Blue Emu Pain Relief Blu Emu69993-100SprayOver the counter monograph drugsJune 4, 2012

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.